Demant A/S reiterated guidance for the year 2021. For the year,the company reiterated organic growth of 26-30% and an EBIT of DKK 3,150-3,450 million for the Group.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
316.2 DKK | -1.43% | +1.67% | +6.82% |
Apr. 08 | Denmark's Demant Finalizes Capital Reduction | MT |
Apr. 04 | Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.82% | 10.01B | |
-8.27% | 16.65B | |
+7.49% | 13.6B | |
-19.87% | 2.01B | |
+6.38% | 1.88B | |
+36.16% | 1.67B | |
+13.95% | 588M | |
0.00% | 492M | |
+26.44% | 139M | |
+12.60% | 104M |
- Stock Market
- Equities
- DEMANT Stock
- News Demant A/S
- Demant A/S Reiterates Guidance for the Year 2021